Swiss National Bank’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-39,300
| Closed | -$589K | – | 2553 |
|
|
2016
Q2 | $589K | Buy |
39,300
+5,700
| +17% | +$73.2K | ﹤0.01% | 2262 |
|
|
2016
Q1 | $393K | Buy |
33,600
+7,000
| +26% | +$98.2K | ﹤0.01% | 2408 |
|
|
2015
Q4 | $423K | Hold |
26,600
| – | – | ﹤0.01% | 2355 |
|
|
2015
Q3 | $408K | Buy |
26,600
+3,900
| +17% | +$84.3K | ﹤0.01% | 2284 |
|
|
2015
Q2 | $552K | Buy |
22,700
+2,300
| +11% | +$55.1K | ﹤0.01% | 2184 |
|
|
2015
Q1 | $474K | Hold |
20,400
| – | – | ﹤0.01% | 2203 |
|
|
2014
Q4 | $512K | Hold |
20,400
| – | – | ﹤0.01% | 2161 |
|
|
2014
Q3 | $634K | Hold |
20,400
| – | – | ﹤0.01% | 1943 |
|
|
2014
Q2 | $528K | Buy |
20,400
+5,900
| +41% | +$131K | ﹤0.01% | 2139 |
|
|
2014
Q1 | $339K | Buy |
14,500
+2,900
| +25% | +$63.4K | ﹤0.01% | 2290 |
|
|
2013
Q4 | $294K | Hold |
11,600
| – | – | ﹤0.01% | 2272 |
|
|
2013
Q3 | $237K | Buy |
11,600
+1,700
| +17% | +$37.8K | ﹤0.01% | 2305 |
|
|
2013
Q2 | $208K | Buy |
+9,900
| New | +$177K | ﹤0.01% | 2349 |
|
Swiss National Bank's SGNT Position: Q3 2016 in Review
Swiss National Bank sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 39,300 shares — an estimated $589K sold.
Swiss National Bank first reported a position in SGNT in Q2 2013 and held it in 13 quarters. The position peaked at $634K in Q3 2014. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.
- Swiss National Bank reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
- Swiss National Bank sold 39,300 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $589K.
- Swiss National Bank first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 13 quarters.
- Swiss National Bank's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $634K in Q3 2014.
- 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.
Based on Swiss National Bank's 13F filing for Q3 2016, filed 7 Nov 2016.